NAM
NorthCrest Asset Manangement’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,105
| Closed | -$288K | – | 641 |
|
|
2025
Q1 | $288K | Buy |
13,105
+5
| +0% | +$110 | 0.01% | 528 |
|
|
2024
Q4 | $297K | Sell |
13,100
-1,092
| -8% | -$24.8K | 0.01% | 486 |
|
|
2024
Q3 | $258K | Buy |
14,192
+12
| +0.1% | +$218 | 0.01% | 508 |
|
|
2024
Q2 | $413K | Hold |
14,180
| – | – | 0.01% | 406 |
|
|
2024
Q1 | $503K | Sell |
14,180
-200
| -1% | -$7.09K | 0.02% | 385 |
|
|
2023
Q4 | $626K | Hold |
14,380
| – | – | 0.02% | 337 |
|
|
2023
Q3 | $549K | Sell |
14,380
-300
| -2% | -$11.5K | 0.02% | 347 |
|
|
2023
Q2 | $604K | Hold |
14,680
| – | – | 0.02% | 327 |
|
|
2023
Q1 | $843K | Buy |
14,680
+500
| +4% | +$28.7K | 0.04% | 285 |
|
|
2022
Q4 | $795K | Buy |
14,180
+380
| +3% | +$21.3K | 0.05% | 215 |
|
|
2022
Q3 | $585K | Hold |
13,800
| – | – | 0.03% | 280 |
|
|
2022
Q2 | $746K | Hold |
13,800
| – | – | 0.04% | 251 |
|
|
2022
Q1 | $887K | Buy |
13,800
+200
| +1% | +$12.9K | 0.04% | 219 |
|
|
2021
Q4 | $911K | Buy |
+13,600
| New | +$911K | 0.05% | 237 |
|